NAT-POMALIDOMIDE

Identification of Nat-Pomalidomide

No description

Google image searchProduct monograph

Active ingredient

pomalidomide, 3 MG

DIN: 02506416

Dosage form(s): CAPSULE

Route(s) of administration: ORAL

Schedule: Prescription

Company: NATCO PHARMA (CANADA) INC

Date: 28-FEB-2023

ATC:

Reference brand drug: Pomalyst

Search on Google